What happens when clinical strategy, bioinformatics, and market access all live under one roof? Meet Tyler O'Malley, VP at Exagen, who shares how this rare triad is driving innovation in autoimmune diagnostics.

In this episode, Tyler reveals how real-world data fuels product strategy, why storytelling is key to market access, and how diagnostic innovators can scale in a payer-driven world. We explore the evolution of evidence, the importance of physician advocacy, and how to align science with unmet clinical need—without chasing shiny objects. Gurus, if you're launching diagnostics or navigating commercialization in today's complex environment, this episode is full of insight you can't afford to miss.